Stay updated on Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial page
- Check7 days agoChange DetectedThe site shows a minor update: a new Revision: v3.4.2 label was added and older Revision: v3.4.1 and a government funding-status notice were removed. These changes do not affect the study content, eligibility criteria, or results, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check14 days agoChange DetectedAdds a government funding notice about the NIH Clinical Center’s status and updates the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedShow glossary option is now displayed on the page, and new metadata items were added: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. The items Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.SummaryDifference0.2%

- Check35 days agoChange DetectedFooter revision label updated from v3.3.3 to v3.3.4. No visible changes to study content or navigation.SummaryDifference0.0%

- Check56 days agoChange DetectedA dedicated Locations section has been added with California listed under it, and the California Locations heading was removed. The HHS Vulnerability Disclosure link was removed from the footer, and the page revision now shows v3.3.3.SummaryDifference0.2%

- Check78 days agoChange Detected- Revision: v3.3.2 is displayed on the page, replacing the previous v3.3.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Chemotherapy in Breast Cancer Clinical Trial page.